Invasion and metastasis in cancer: molecular insights and therapeutic targets

Yongxing Li1,2, Fengshuo Liu3,4,5,6,7, Qingjin Cai1,2

  • 1Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Insights

Tumor metastasis causes secondary tumors, impacting patient survival. This study examines metastasis mechanisms and therapeutic strategies, focusing on organ tropism and emerging treatments for better patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Malignant tumor progression often results in secondary tumors in organs like bone, brain, liver, and lungs.
  • Tumor metastasis significantly worsens patient prognosis, quality of life, and survival rates.
  • Current research often focuses on specific cancer types, leaving gaps in understanding the metastatic cascade and organ tropism.

Purpose of the Study:

  • To examine the sequential processes of tumor metastasis.
  • To elucidate mechanisms driving organ-tropic metastasis.
  • To systematically analyze therapeutic strategies for metastatic tumors, including organ-specific treatments and emerging technologies.

Main Methods:

  • Review and synthesis of existing literature on tumor metastasis.
  • Analysis of biological mechanisms underlying organ-specific metastasis.
  • Evaluation of current and emerging therapeutic strategies for metastatic cancers.
  • Examination of challenges and opportunities in clinical research for bone metastasis.

Main Results:

  • Detailed examination of the sequential steps in tumor metastasis.
  • Elucidation of key mechanisms responsible for organ-specific metastasis (tropism).
  • Systematic analysis of therapeutic interventions, including novel approaches for metastatic tumors.
  • Identification of challenges and future directions in bone metastasis research.

Conclusions:

  • A comprehensive understanding of metastasis mechanisms is crucial for improving patient outcomes.
  • Targeted therapies and emerging technologies hold promise for treating metastatic disease.
  • Further research, particularly on organ tropism and bone metastasis, is needed to advance clinical practice.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...